This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2010
Title: The Innovations of Carl-Gustaf Sigfridsson
Introduction
Carl-Gustaf Sigfridsson is a notable inventor based in Molndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as prodrugs for competitive inhibitors of trypsin-like proteases.
Latest Patents
Carl-Gustaf Sigfridsson holds 2 patents. His latest patents focus on pharmaceutically-acceptable acid addition salts of compounds that are useful in the treatment of conditions requiring the inhibition of thrombin, such as thrombosis. These compounds are characterized by specific alkyl substitutions and are designed to enhance the efficacy of anticoagulants.
Career Highlights
He is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in the medical field, particularly in drug development.
Collaborations
Throughout his career, Carl-Gustaf has collaborated with esteemed colleagues, including Martin Hans Bohlin and Tord Bertil Inghardt. These collaborations have further enriched his research and development efforts.
Conclusion
Carl-Gustaf Sigfridsson's work exemplifies the impact of innovation in pharmaceuticals, particularly in the development of treatments that address critical health issues. His contributions continue to influence the field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile